The global intravenous infusion pump market size was valued at USD 5.30 Billion in 2024, driven by the rising prevalence of chronic diseases across the globe. The market is expected to grow at a CAGR of 7.60% during the forecast period of 2025-2034, with the values likely to rise from to USD 11.03 Billion by 2034.
Infusion pumps can be stationary or portable depending on the patient's requirement. Some pumps are equipped with safety measures like an alarm clock or other operator alerts as well. They may be mechanically or electrically powered.
Recently, FDA approved the redistribution of BD's Alaris infusion pump in the market. This latest version is enabled with new software, hardware, and cybersecurity updates to deliver precise medications to the patients.
In August 2023, ICU Medical received 510(k) FDA clearance to its Plum Duo infusion pump, enabled with LifeShield infusion safety software. This pump features a large touch screen that enables an intuitive user interface as well. Similarly, Baxter's Novum IQ syringe infusion pump (SYR) is paired with Dose IQ safety software that provides enhanced safety features, connectivity and a vast portfolio of sets designed to deliver optimum dose precision.
With a surge in innovations and digital integration into healthcare and medical devices, IOT (internet of things) controlled devices are set to emerge in the market. Researchers are working on developing remote monitoring enabled infusion pumps for accurate detection of patient's vitals. Such technologies will enhance the intravenous infusion pump market growth in the upcoming years.
This product will be delivered within 3-5 business days.
Intravenous Infusion Pump: Introduction
An intravenous infusion pump is a device used to administer medication or fluids into a patient's body for treating high blood pressure. They offer significant advantage over manual administration as it capable of delivering fluids at precisely programmed intervals and in smaller volumes as well.Infusion pumps can be stationary or portable depending on the patient's requirement. Some pumps are equipped with safety measures like an alarm clock or other operator alerts as well. They may be mechanically or electrically powered.
Global Intravenous Infusion Pump Market Analysis
Intravenous infusion must be highly precise because even minute changes can threaten a patient's life. As a result, authorities like the FDA and EU continuously evaluate the efficacy of prevailing devices. To curb the high intravenous infusion pump market demand, prominent healthcare companies keep on bringing updated versions of devices.Recently, FDA approved the redistribution of BD's Alaris infusion pump in the market. This latest version is enabled with new software, hardware, and cybersecurity updates to deliver precise medications to the patients.
In August 2023, ICU Medical received 510(k) FDA clearance to its Plum Duo infusion pump, enabled with LifeShield infusion safety software. This pump features a large touch screen that enables an intuitive user interface as well. Similarly, Baxter's Novum IQ syringe infusion pump (SYR) is paired with Dose IQ safety software that provides enhanced safety features, connectivity and a vast portfolio of sets designed to deliver optimum dose precision.
With a surge in innovations and digital integration into healthcare and medical devices, IOT (internet of things) controlled devices are set to emerge in the market. Researchers are working on developing remote monitoring enabled infusion pumps for accurate detection of patient's vitals. Such technologies will enhance the intravenous infusion pump market growth in the upcoming years.
Global Intravenous Infusion Pump Market Segmentation
Intravenous Infusion Pump Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:Market Breakup by Type
- Volumetric Infusion Pumps
- Syringe Infusion Pumps
- Patient Controlled Analgesia Infusion Pumps
Market Breakup by Applications
- Oncology
- Parenteral Nutrition
- Analgesia/Pain Management
- Others
Market Breakup by End User
- Hospital and Clinics
- Home Healthcare
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
This product will be delivered within 3-5 business days.
Table of Contents
1 Preface
3 Global Intravenous Infusion Pump Market Overview
4 Global Intravenous Infusion Pump Market Landscape
5 Global Intravenous Infusion Pump Market Dynamics
6 Global Intravenous Infusion Pump Market Segmentation
7 North America Intravenous Infusion Pump Market
8 Europe Intravenous Infusion Pump Market
9 Asia Pacific Intravenous Infusion Pump Market
10 Latin America Intravenous Infusion Pump Market
11 Middle East and Africa Intravenous Infusion Pump Market
12 Patent Analysis
13 Grants Analysis
14 Funding and Investment Analysis
15 Partnership and Collaborations Analysis
16 Supplier Landscape
18 Company Competitiveness Analysis (Additional Insight)
19 Payment Methods (Additional Insight)
Companies Mentioned
- F. Hoffmann-La Roche Ltd.
- Fresenius SE & Co. KGaA
- B. Braun
- Becton, Dickinson and Company
- Baxter
- Terumo Corporation
- Medtronic Plc
- Smith Medical
- ICU Medical
- Tandem Diabetes Care, Inc
